Ballicules.com

Esomeprazole

NEXIUM

What it isProton-pump inhibitor, the S-enantiomer of omeprazole; GERD and ulcer disease.

Why this oneIt provides somewhat more consistent acid suppression than racemic omeprazole.

What limits itLong-term use can deplete magnesium and B12 and increase fracture risk; reassess the indication periodically.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Frequent heartburn (OTC)Adults >=18 y1 capsule (20 mg) QD x14 days1 capsule QD x14 days1 capsule/day

Renal Undefined

Hepatic Undefined

OTC label; may take 1-4 days for full effect

Instructions

Pregnancy Undefined

Lactation Undefined

NO BOXED WARNINGS

Principal riskLong-term use: B12 deficiency, hypomagnesemia, fracture

Cost, est. cash$10–$500/month

Generic entry2013

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryB

Defining liabilityLong-term infection, magnesium/B12 and bone risks; selected agents have clinically important CYP interactions.

Mechanism of action: Esomeprazole ballicule

Esomeprazole ballicule: receptor binding, kinetics and half-life diagram

Open Esomeprazole in the interactive console ↗

Memory aids: mascots and interaction avatars

Esomeprazole NEXIUM mascot mnemonic cartoon
“Neck see S only”
single-enantiomer omeprazole: the S-enantiomer only
Esomeprazole CYP2C19 inhibitor avatar
CYP2C19 inhibitor (moderate)
Esomeprazole CYP2C19 substrate avatar
CYP2C19 substrate

Open Esomeprazole in the interactive console ↗